| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,924 |
3,671 |
$228K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,900 |
3,224 |
$121K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
975 |
942 |
$96K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,003 |
1,001 |
$85K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
904 |
895 |
$72K |
| 92587 |
|
1,833 |
1,814 |
$58K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
689 |
689 |
$58K |
| 90461 |
|
1,272 |
1,270 |
$37K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,659 |
3,644 |
$33K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
641 |
615 |
$33K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
325 |
324 |
$30K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,118 |
2,055 |
$22K |
| 99051 |
|
1,217 |
1,172 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
666 |
638 |
$16K |
| 99173 |
|
810 |
810 |
$16K |
| 96127 |
|
1,478 |
1,475 |
$15K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
681 |
659 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,401 |
1,370 |
$11K |
| 36416 |
|
661 |
645 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
390 |
388 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
111 |
110 |
$9K |
| 99177 |
|
549 |
549 |
$7K |
| 83655 |
|
640 |
636 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
462 |
449 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
61 |
61 |
$5K |
| 99188 |
|
180 |
180 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
182 |
182 |
$4K |
| 99384 |
|
25 |
25 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
84 |
83 |
$3K |
| 87081 |
|
306 |
304 |
$2K |
| 0072A |
|
35 |
34 |
$2K |
| 0071A |
|
30 |
30 |
$1K |
| 92552 |
|
50 |
50 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
103 |
59 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
38 |
38 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
38 |
38 |
$1K |
| 99383 |
|
12 |
12 |
$1K |
| 87634 |
|
15 |
15 |
$928.80 |
| 87070 |
|
50 |
48 |
$833.88 |
| 92551 |
|
15 |
15 |
$148.95 |
| 81000 |
|
14 |
13 |
$138.04 |
| 81002 |
|
28 |
25 |
$74.45 |
| 94760 |
|
35 |
33 |
$69.30 |
| 99000 |
|
62 |
62 |
$62.00 |
| 85018 |
|
12 |
12 |
$25.29 |